# Intraoperative Margin Assessment in Breast Cancer With HSI-Raman

> **NCT07111728** · — · RECRUITING · sponsor: **Istituti Clinici Scientifici Maugeri SpA** · enrollment: 104 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Spectra-BREAST system in Invasive Breast Cancer
- **DIAGNOSTIC_TEST:** Spectra-BREAST system in DCIS Breast Cancer

## Key facts

- **NCT ID:** NCT07111728
- **Lead sponsor:** Istituti Clinici Scientifici Maugeri SpA
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-06
- **Primary completion:** 2028-10
- **Final completion:** 2028-12
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07111728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07111728, "Intraoperative Margin Assessment in Breast Cancer With HSI-Raman". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07111728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*